Latest data from the Hong Kong Stock Exchange reveals that on November 25, JPMorgan reduced its holdings in TIGERMED (03347) by 831,247 shares at an average price of HK$39.8240 per share, totaling approximately HK$33.1036 million. Following this reduction, JPMorgan's latest shareholding stands at about 9.5093 million shares, representing a 7.72% stake in the company.